Shares of Tilray Brands surged 11.9% to $2.96 after the cannabis-and-beverage conglomerate nudged its earnings forecast higher and announced it would shut down a Canadian facility to save money. For a company that posted record revenue of nearly $1 billion last year yet still loses money on a per-share basis, the question is whether trimming costs can accomplish what top-line growth has not: a path to real profitability.
A Modest Guidance Bump Signals Management Is More Confident — But Not By Much
Tilray raised the lower end of its fiscal 2027 adjusted EBITDA guidance — a measure of operating profit before certain accounting adjustments — to $70 million, up from $68 million, keeping the ceiling at $75 million. That's a $2 million increase at the floor, roughly a 3% lift. The revision reflects management's confidence in ongoing cost-cutting initiatives and operational improvements. Encouraging, but hardly transformative for a company with a trailing twelve-month loss of -$1.40 per share. The P/E ratio is not applicable because earnings remain negative.
Closing a Factory Could Save $10 Million a Year — Starting Next Fiscal Year
Tilray will consolidate Canadian cannabis operations by transitioning cultivation and pre-roll production from its Foss facility in Fenwick, Ontario, to its Masson, Quebec, and Cayuga, Ontario, facilities.
The consolidation is expected to generate approximately $10 million in annualized cost savings by the end of fiscal 2028.
Greater-than-expected yields at Masson gave the company flexibility to optimize production and reduce costs. Critically, these savings only reach full run-rate next fiscal year, not this one.
Pre-Rolls Are Growing Fast, But Cannabis Revenue Is Under Pressure
Pre-rolls account for about a third of Tilray's Canadian adult-use sales and grew 28% in fiscal 2026. Yet the consolidation comes as sales in its cannabis segment continue to decline. The company is leaning on its beverage, pharmaceutical-distribution, and wellness divisions to diversify. Management expects over $1 billion in annual revenue for fiscal 2027.
The Bigger Picture: Cost Discipline Meets a $2.96 Stock
Tilray is also restructuring its U.S. brewing footprint and trimming slow-selling products, seeking an additional $20 million in cost cuts by fiscal 2028. Combined with the Canadian savings, that's $30 million in targeted annual reductions. For shareholders, the math is straightforward: if Tilray hits $75 million in EBITDA and layers on $30 million in savings, the business starts to look meaningfully different. But that payoff is still a full fiscal year away, and the stock's decade-long decline means investors have heard these promises before.